BIO Asia–Taiwan 2025, Taiwan’s well-known biotech exhibition, is taking place from July 24 to 26. Today (July 25), Taiwan Bio-Manufacturing Corporation (TBMC) is hosting a media gathering at its booth to unveil its vision of “Being a World-Class Bio-Manufacturing CRDMO.”

TBMC announced that construction of its Zhubei GMP facility began in June and is on track for first-phase completion this (2025) December. Featuring a modular design, the facility supports the production of mRNA vaccines, nucleic acid drugs, viral vectors, and cell therapies, meets international standards, and marks a milestone in providing one-stop CRDMO services from process development to commercialization.